Search results
Uproleselan’s failed Phase III AML trial shakes up GlycoMimetics’ future
Clinical Trials Arena via Yahoo Finance· 1 month agoOn 6 May 2024, US-based biotech GlycoMimetics announced that its E-selectin inhibitor candidate...
Kura Oncology, Inc. (NASDAQ:KURA) Q4 2023 Earnings Call Transcript
Insider Monkey via Yahoo Finance· 3 months agoKura Oncology, Inc. (NASDAQ:KURA) Q4 2023 Earnings Call Transcript February 27, 2024 Kura Oncology,...
GlycoMimetics (GLYC) Q2 2022 Earnings Call Transcript
Motley Fool· 2 years agoGood morning, and thank you for joining the GlycoMimetics Q2 2022 earnings call. Brian will then...